Huinno Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
78
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
33
Huinno General Information
Description
Developer of a clinical decision support system with AI-based cloud analysis software designed to provide biosignal data of ill patients. The company's system uses sensors and algorithms to monitor health data like blood pressure, and heart rate and also provides convenient diagnosis and treatment of patients with cardiac diseases such as arrhythmia, atrial fibrillation, and hypertension, enabling healthcare professionals to diagnose and make informed medical decisions while treating a patient.
Contact Information
Website
www.huinno.comCorporate Office
- 4th floor, Rain Avenue
- 19 Apgujeong-ro 79-gil
- Seoul, Gangnam-gu 06011
- South Korea
Corporate Office
- 4th floor, Rain Avenue
- 19 Apgujeong-ro 79-gil
- Seoul, Gangnam-gu 06011
- South Korea
Huinno Timeline
Huinno Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
13. Accelerator/Incubator | 000.00 | Completed | Generating Revenue | |||
12. Accelerator/Incubator | 000.00 | Completed | Generating Revenue | |||
11. Accelerator/Incubator | 000.00 | Completed | Generating Revenue | |||
10. Later Stage VC (Series C) | 07-Dec-2021 | 000.00 | 000.00 | Completed | Generating Revenue | |
9. Accelerator/Incubator | 30-May-2021 | 000.00 | Completed | Generating Revenue | ||
8. Later Stage VC (Series B) | 21-Dec-2020 | 000.00 | 000.00 | Completed | Generating Revenue | |
7. Later Stage VC | 01-Feb-2020 | 00.000 | 000.00 | Completed | Generating Revenue | |
6. Later Stage VC (Series A) | 20-Aug-2019 | 00.00 | 0000 | Completed | Generating Revenue | |
5. Early Stage VC (Series A) | 19-Aug-2016 | $4.12M | $4.12M | 000.00 | Completed | Generating Revenue |
4. Accelerator/Incubator | 13-Nov-2015 | Completed | Pre-Clinical Trials |
Huinno Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 000 |
Huinno Comparisons
Industry
Financing
Details
Huinno Competitors (30)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Retia Medical | Venture Capital-Backed | White Plains, NY | 00 | 0000 | 0000000000 0 | 0000 |
Bardy Diagnostics | Formerly VC-backed | Bellevue, WA | 000 | 000.00 | 000000&0 | 000.00 |
Agatsa | Venture Capital-Backed | Noida, India | 00 | 00.00 | 000000 0 | |
AliveCor | Venture Capital-Backed | Mountain View, CA | 000 | 00000 | 000000000 | 00000 |
Stasis | Venture Capital-Backed | Los Angeles, CA | 00 | 00.000 | 000000000000 | 00.000 |
Huinno Patents
Huinno Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20240215892-A1 | Device for monitoring biosignal | Pending | 31-Aug-2022 | 000000000 | |
US-20240215925-A1 | Method, system, and non-transitory computer-readable recording medium for estimating arrhythmia using composite artificial neural network | Pending | 30-Aug-2022 | 00000000 | |
US-20240016434-A1 | Method, system and non-transitory computer-readable recording medium for detecting and classifying beat in electrocardiogram signal | Pending | 08-Jul-2022 | 000000000 | |
US-20240152808-A1 | Method, system, and non-transitory computer-readable recording medium for managing training data of biosignal analysis model | Pending | 20-Jul-2021 | 000000000 | |
US-20240153646-A1 | Method, system, and non-transitory computer-readable recording medium for managing output data of biosignal analysis model | Pending | 16-Jul-2021 | G16H50/70 |
Huinno Executive Team (7)
Name | Title | Board Seat |
---|---|---|
Yeongjoon Gil Ph.D | Founder, Chief Executive Officer & President | |
Sunghoon Jeong Ph.D | Chief Technology Officer | |
Ji Hwan Kim | Chief Product Officer |
Huinno Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Ryu Jung-hee | Self | Board Member | 000 0000 |
Huinno Signals
Huinno Investors (33)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
AON Investment | Venture Capital | Minority | 000 0000 | 000000 0 |
DAOL Investment | Venture Capital | Minority | 000 0000 | 000000 0 |
FuturePlay | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
Groom Investment | PE/Buyout | Minority | 000 0000 | 000000 0 |
Meritz Securities | Investment Bank | Minority | 000 0000 | 000000 0 |
Huinno Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Huinno Aim | 17-Aug-2022 | 0000 00000 | 00.000 | Decision/Risk Analysis |
Huinno FAQs
-
When was Huinno founded?
Huinno was founded in 2014.
-
Who is the founder of Huinno?
Yeongjoon Gil Ph.D, Steven Baek, and Yeongjoon Gil are the founders of Huinno.
-
Who is the CEO of Huinno?
Yeongjoon Gil Ph.D is the CEO of Huinno.
-
Where is Huinno headquartered?
Huinno is headquartered in Seoul, South Korea.
-
What is the size of Huinno?
Huinno has 78 total employees.
-
What industry is Huinno in?
Huinno’s primary industry is Monitoring Equipment.
-
Is Huinno a private or public company?
Huinno is a Private company.
-
What is Huinno’s current revenue?
The current revenue for Huinno is 00000.
-
How much funding has Huinno raised over time?
Huinno has raised $70.2M.
-
Who are Huinno’s investors?
AON Investment, DAOL Investment, FuturePlay, Groom Investment, and Meritz Securities are 5 of 33 investors who have invested in Huinno.
-
Who are Huinno’s competitors?
Retia Medical, Bardy Diagnostics, Agatsa, AliveCor, and Stasis are some of the 30 competitors of Huinno.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »